Recent News

By Region: North America

Airflow problems plague CDC bioterror lab

(USA TODAY) A $214 million bioterror germ lab at the Centers for Disease Control and Prevention in Atlanta has had repeated problems with airflow systems designed to help prevent the release of infectious agents, government documents and internal e-mails show. While the agency says no one has been infected, a biosafety expert says the problems Read More »

June 14, 2012
| Filed under North America, Biosafety, Policy & Initiatives, and Research
Share

DoD Chem Defense Researchers Host Successful Bioscience Review

(Global Biodefense) The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) hosted its 18th Biennial Medical Defense Bioscience Review last month in Hunt Valley, Md. The conference highlights research to improve medical countermeasures against the effects of biological neurotoxins, chemical warfare agents, and toxic industrial chemicals.

June 14, 2012
| Filed under North America and Research
Share

Gazette opinion: Absurd federal rule blocks vaccine research

(Billings Gazette) On May 29, Sens. Jon Tester and Max Baucus urged federal research regulators to reconsider restrictions that effectively block research to develop vaccines against brucellosis. The senators and Rep. Denny Rehberg previously have sought to remove this government impediment to important research. The Interagency Bison Management Plan partners asked the Montana delegation to Read More »

June 13, 2012
| Filed under North America, Agriculture, Countermeasures, Policy & Initiatives, and Research
Share

Potential Consequences of FMD Outbreak Examined

(ThePigSite.com) An economics professor with Iowa State University estimates the American pork industry would lose an average of $1.8 billion per year over 10 years in the event of a foot and mouth disease outbreak in the United States, writes Bruce Cochrane. Foot and mouth disease is a highly infectious viral disease that affects cloven-hooved Read More »

June 13, 2012
| Filed under North America, Agriculture, and Policy & Initiatives
Share

Siga appeals PharmAthene smallpox drug ruling

(CBS News) NEW YORK — Siga Technologies Inc. said Tuesday that it is appealing a ruling that awarded about half the profits on its smallpox drug to PharmAthene Inc. Siga said it filed an appeal to overturn the Delaware Chancery Court decision. The court ruled May 31 that after Siga makes its first $40 million Read More »